The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
In a landmark ruling reshaping one of corporate America's biggest legal battles, the US Supreme Court voted 7-2 in favor of Bayer in Monsanto v. Durnell, holding that federal pesticide law preempts state failure-to-warn claims over the Roundup herbicide. The court threw out a $1.25 million jury verdict for a Missouri plaintiff. Bayer shares surged 20% in Frankfurt, marking their largest intraday gain.
Sign in to access this content
Sign InThe ruling eliminates the core legal theory behind tens of thousands of pending lawsuits against Bayer over Roundup, potentially saving the company billions of dollars in settlements. Per market data, Bayer's US-listed shares (BAYRY) closed at $11.25 on June 24, after touching an intraday high of $11.39. Analysts had previously estimated Bayer's Roundup-related liabilities at over $10 billion, but the ruling fundamentally changes those calculations.
Going forward, attention turns to how Bayer handles remaining lawsuits not covered by this ruling and the decision's impact on other companies facing similar claims. The stock now faces a test to hold above $11, with positive sentiment potentially driving it toward new highs. No major economic events in the coming days directly affect the stock.